Selected research
Industry Research
Human Serum and Plasma Industry Research Report 2026
Market perspective
The global Human Serum and Plasma market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Serum and Plasma is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Serum and Plasma is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Serum and Plasma is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Serum and Plasma include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Serum and Plasma market in revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Human Serum and Plasma.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Serum and Plasma Market by Company
Thermo Fisher
Merck Millipore
Baxter
Zen-Bio
Trina Bioreactives
TCS Biosciences Ltd
SeraCare
Monobind
Cytiva
Akron
Human Serum and Plasma Segment by Type
Fresh Human Serum and Plasma
Frozen Human Serum and Plasma
Human Serum and Plasma Segment by Application
Vaccines and Antibodies
Cell Culture
In Vitro Diagnostics
Clinical Research
Others
Human Serum and Plasma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum and Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Serum and Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Serum and Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Serum and Plasma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Serum and Plasma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Serum and Plasma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fresh Human Serum and Plasma
- Frozen Human Serum and Plasma
Applications
- Vaccines and Antibodies
- Cell Culture
- In Vitro Diagnostics
- Clinical Research
- Others
Companies covered
- Thermo Fisher
- Merck Millipore
- Baxter
- Zen-Bio
- Trina Bioreactives
- TCS Biosciences Ltd
- SeraCare
- Monobind
- Cytiva
- Akron
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Human Serum and Plasma by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Fresh Human Serum and Plasma
- 2.2.3 Frozen Human Serum and Plasma
- 2.3 Human Serum and Plasma by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vaccines and Antibodies
- 2.3.3 Cell Culture
- 2.3.4 In Vitro Diagnostics
- 2.3.5 Clinical Research
- 2.3.6 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Human Serum and Plasma Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Human Serum and Plasma Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Human Serum and Plasma Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Human Serum and Plasma Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Serum and Plasma Production by Manufacturers (2021-2026)
- 3.2 Global Human Serum and Plasma Production Value by Manufacturers (2021-2026)
- 3.3 Global Human Serum and Plasma Average Price by Manufacturers (2021-2026)
- 3.4 Global Human Serum and Plasma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Human Serum and Plasma Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Human Serum and Plasma Manufacturers, Product Type & Application
- 3.7 Global Human Serum and Plasma Manufacturers Established Date
- 3.8 Global Human Serum and Plasma Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher
- 4.1.1 Thermo Fisher Human Serum and Plasma Company Information
- 4.1.2 Thermo Fisher Human Serum and Plasma Business Overview
- 4.1.3 Thermo Fisher Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Product Portfolio
- 4.1.5 Thermo Fisher Recent Developments
- 4.2 Merck Millipore
- 4.2.1 Merck Millipore Human Serum and Plasma Company Information
- 4.2.2 Merck Millipore Human Serum and Plasma Business Overview
- 4.2.3 Merck Millipore Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.2.4 Merck Millipore Product Portfolio
- 4.2.5 Merck Millipore Recent Developments
- 4.3 Baxter
- 4.3.1 Baxter Human Serum and Plasma Company Information
- 4.3.2 Baxter Human Serum and Plasma Business Overview
- 4.3.3 Baxter Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.3.4 Baxter Product Portfolio
- 4.3.5 Baxter Recent Developments
- 4.4 Zen-Bio
- 4.4.1 Zen-Bio Human Serum and Plasma Company Information
- 4.4.2 Zen-Bio Human Serum and Plasma Business Overview
- 4.4.3 Zen-Bio Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.4.4 Zen-Bio Product Portfolio
- 4.4.5 Zen-Bio Recent Developments
- 4.5 Trina Bioreactives
- 4.5.1 Trina Bioreactives Human Serum and Plasma Company Information
- 4.5.2 Trina Bioreactives Human Serum and Plasma Business Overview
- 4.5.3 Trina Bioreactives Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.5.4 Trina Bioreactives Product Portfolio
- 4.5.5 Trina Bioreactives Recent Developments
- 4.6 TCS Biosciences Ltd
- 4.6.1 TCS Biosciences Ltd Human Serum and Plasma Company Information
- 4.6.2 TCS Biosciences Ltd Human Serum and Plasma Business Overview
- 4.6.3 TCS Biosciences Ltd Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.6.4 TCS Biosciences Ltd Product Portfolio
- 4.6.5 TCS Biosciences Ltd Recent Developments
- 4.7 SeraCare
- 4.7.1 SeraCare Human Serum and Plasma Company Information
- 4.7.2 SeraCare Human Serum and Plasma Business Overview
- 4.7.3 SeraCare Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.7.4 SeraCare Product Portfolio
- 4.7.5 SeraCare Recent Developments
- 4.8 Monobind
- 4.8.1 Monobind Human Serum and Plasma Company Information
- 4.8.2 Monobind Human Serum and Plasma Business Overview
- 4.8.3 Monobind Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.8.4 Monobind Product Portfolio
- 4.8.5 Monobind Recent Developments
- 4.9 Cytiva
- 4.9.1 Cytiva Human Serum and Plasma Company Information
- 4.9.2 Cytiva Human Serum and Plasma Business Overview
- 4.9.3 Cytiva Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.9.4 Cytiva Product Portfolio
- 4.9.5 Cytiva Recent Developments
- 4.10 Akron
- 4.10.1 Akron Human Serum and Plasma Company Information
- 4.10.2 Akron Human Serum and Plasma Business Overview
- 4.10.3 Akron Human Serum and Plasma Production, Value and Gross Margin (2021-2026)
- 4.10.4 Akron Product Portfolio
- 4.10.5 Akron Recent Developments
5 Global Human Serum and Plasma Production by Region
- 5.1 Global Human Serum and Plasma Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Serum and Plasma Production by Region: 2021-2032
- 5.2.1 Global Human Serum and Plasma Production by Region: 2021-2026
- 5.2.2 Global Human Serum and Plasma Production Forecast by Region (2027-2032)
- 5.3 Global Human Serum and Plasma Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Human Serum and Plasma Production Value by Region: 2021-2032
- 5.4.1 Global Human Serum and Plasma Production Value by Region: 2021-2026
- 5.4.2 Global Human Serum and Plasma Production Value Forecast by Region (2027-2032)
- 5.5 Global Human Serum and Plasma Market Price Analysis by Region (2021-2026)
- 5.6 Global Human Serum and Plasma Production and Value, YOY Growth
- 5.6.1 North America Human Serum and Plasma Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Human Serum and Plasma Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Human Serum and Plasma Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Human Serum and Plasma Production Value Estimates and Forecasts (2021-2032)
6 Global Human Serum and Plasma Consumption by Region
- 6.1 Global Human Serum and Plasma Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Human Serum and Plasma Consumption by Region (2021-2032)
- 6.2.1 Global Human Serum and Plasma Consumption by Region: 2021-2026
- 6.2.2 Global Human Serum and Plasma Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Human Serum and Plasma Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Human Serum and Plasma Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Human Serum and Plasma Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Human Serum and Plasma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Human Serum and Plasma Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Human Serum and Plasma Production by Type (2021-2032)
- 7.1.1 Global Human Serum and Plasma Production by Type (2021-2032) & (Units)
- 7.1.2 Global Human Serum and Plasma Production Market Share by Type (2021-2032)
- 7.2 Global Human Serum and Plasma Production Value by Type (2021-2032)
- 7.2.1 Global Human Serum and Plasma Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Human Serum and Plasma Production Value Market Share by Type (2021-2032)
- 7.3 Global Human Serum and Plasma Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Human Serum and Plasma Production by Application (2021-2032)
- 8.1.1 Global Human Serum and Plasma Production by Application (2021-2032) & (Units)
- 8.1.2 Global Human Serum and Plasma Production Market Share by Application (2021-2032)
- 8.2 Global Human Serum and Plasma Production Value by Application (2021-2032)
- 8.2.1 Global Human Serum and Plasma Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Human Serum and Plasma Production Value Market Share by Application (2021-2032)
- 8.3 Global Human Serum and Plasma Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Human Serum and Plasma Value Chain Analysis
- 9.1.1 Human Serum and Plasma Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Human Serum and Plasma Production Mode & Process
- 9.2 Human Serum and Plasma Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Human Serum and Plasma Distributors
- 9.2.3 Human Serum and Plasma Customers
10 Global Human Serum and Plasma Analyzing Market Dynamics
- 10.1 Human Serum and Plasma Industry Trends
- 10.2 Human Serum and Plasma Industry Drivers
- 10.3 Human Serum and Plasma Industry Opportunities and Challenges
- 10.4 Human Serum and Plasma Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst